Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation by Lyratzopoulos, Georgios et al.
Understanding missed opportunities
for more timely diagnosis of cancer in
symptomatic patients after presentation
G Lyratzopoulos*,1,2, P Vedsted3 and H Singh4
1Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, 1-19 Torrington
Place, London WC1E 6BT, UK; 2Department of Public Health and Primary Care, Cambridge Centre for Health Services Research,
University of Cambridge, Institute of Public Health, Forvie Site, Robinson Way, Cambridge CB2 0SR, UK; 3Department of Public
Health, Research Unit for General Practice, Research Centre for Cancer Diagnosis in Primary Care (CaP), Aarhus University,
DK-Bartholins Alle´, 8000 Aarhus, Denmark and 4Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and
Safety, Michael E. DeBakey Veterans Affairs Medical Center and the Section of Health Services Research, Department of
Medicine, Baylor College of Medicine, Houston TX 77030, US
Abstract: The diagnosis of cancer is a complex, multi-step process. In this paper, we highlight factors involved in missed
opportunities to diagnose cancer more promptly in symptomatic patients and discuss responsible mechanisms and potential
strategies to shorten intervals from presentation to diagnosis. Missed opportunities are instances in which post-hoc judgement
indicates that alternative decisions or actions could have led to more timely diagnosis. They can occur in any of the three phases of
the diagnostic process (initial diagnostic assessment; diagnostic test performance and interpretation; and diagnostic follow-up and
coordination) and can involve patient, doctor/care team, and health-care system factors, often in combination. In this perspective
article, we consider epidemiological ‘signals’ suggestive of missed opportunities and draw on evidence from retrospective case
reviews of cancer patient cohorts to summarise factors that contribute to missed opportunities. Multi-disciplinary research targeting
such factors is important to shorten diagnostic intervals post presentation. Insights from the fields of organisational and cognitive
psychology, human factors science and informatics can be extremely valuable in this emerging research agenda. We provide a
conceptual foundation for the development of future interventions to minimise the occurrence of missed opportunities in cancer
diagnosis, enriching current approaches that chiefly focus on clinical decision support or on widening access to investigations.
The diagnosis of cancer in symptomatic patients requires a
complex, multi-step process. Consequently, some patients experience
prolonged intervals to diagnosis, which arise from various patient,
doctor and health-care system-related factors involved in this
process. Prompt diagnosis in symptomatic cancer patients
represents a core deliverable of modern health-care systems, and
the public (including patients, politicians and the media) considers
it a serious priority. However, tensions between societal expecta-
tions for prompt cancer diagnosis in all patients and the challenges
involved in achieving this aim are being increasingly recognised by
patient groups, health-care professionals and policy makers.
Research on strategies to minimise prolonged diagnostic intervals
after presentation has become a priority. The objectives of this
article are to highlight factors involved in missed opportunities
for cancer diagnosis among symptomatic patients and discuss
potential mechanisms and approaches to accelerating progress
towards minimising diagnostic delays post presentation. We
provide a conceptual foundation for developing multi-faceted
strategies to achieve timely diagnosis in the greatest possible
numbers of patients post presentation.
RETROSPECTIVE CASE ANALYSES SUGGESTIVE OF
MISSED DIAGNOSTIC OPPORTUNITIES
A large body of evidence based on analysis of the clinical details of
cohorts of cancer patients suggests that ‘missed opportunities’
*Correspondence: Dr G Lyratzopoulos; E-mail: gl290@medschl.cam.ac.uk
Published online 3 March 2015
& 2015 Cancer Research UK. All rights reserved 0007 – 0920/15
FULL PAPER
Keywords: neoplasm; diagnosis; missed opportunities; patient safety; general practice; system factors; errors; quality
British Journal of Cancer (2015) 112, S84–S91 | doi: 10.1038/bjc.2015.47
S84 www.bjcancer.com |DOI:10.1038/bjc.2015.47
occur in substantial proportions of patients (Singh et al, 2007,
2009a, 2010). A related concept is that of ‘quality deviations’ in the
diagnosis of cancer (Jensen et al, 2014). A recent UK study also
documents missed opportunities (Mitchell et al, 2013). Missed
opportunities are instances in which post-hoc judgement indicates
that alternative decisions or actions could have led to more timely
diagnosis—i.e., something different could have been done or
considered under the given circumstances to reach a more prompt
diagnosis (Singh, 2014). For example, absence of evaluation for
possible gastrointestinal bleeding in a 50-year-old man with new
onset iron deficiency anaemia could represent a missed diagnostic
opportunity for more timely diagnosis of gastrointestinal cancer.
Determining the presence of missed opportunity involves a process
of retrospective adjudication typically based on patient record
audits, but it helps uncover critical areas for improvements in
diagnostic quality.
It should be emphasised that not all missed opportunities or
delays necessarily result in harm or poor patient outcomes and not
all instances of delayed diagnosis are associated with missed
opportunities (Figure 1; Singh, 2014). Missed opportunities may
relate to any disease; for example, six out of seven patients
subsequently diagnosed with chronic obstructive pulmonary
disease are reported to have experienced missed opportunities,
and very long diagnostic delays are reported among patients with
ankylosing spondylitis (Hamilton et al, 2011; Jones et al, 2014). In
this paper nonetheless we focus solely on patients with cancer who
have sought medical help for their symptoms and exclude the
consideration of potential opportunities for earlier presentation or
participation in screening programmes.
EPIDEMIOLOGICAL SIGNALS OF MISSED DIAGNOSTIC
OPPORTUNITIES
Retrospective evaluation of individual cases is not the only source
of evidence on missed diagnostic opportunities. In England, work
conducted by the (former) National Patient Safety Agency has
highlighted factors implicated in diagnostic delays in cancer and
recommended ‘routine monitoring of delayed diagnosis’ (NPSA,
2010). Although thus far no system that allows such routine
monitoring exists, epidemiological evidence from England
indicates that about one in five patients seen in general practice
and subsequently diagnosed with cancer consults with their
general practitioners three or more times for relevant symptoms
before a specialist referral is made and that instances of multiple
consultations are associated with prolonged primary care
intervals (Lyratzopoulos et al, 2012, 2013a). Similarly, evidence
from Denmark indicates that the rate of primary care consulta-
tions, diagnostic tests and hospital visits among patients
subsequently diagnosed with cancer is substantially higher than
that of ‘control’ patients (without cancer), over a period of several
months before diagnosis (Figure 2) (Christensen et al, 2012;
Ahrensberg et al, 2013; Hansen et al, 2015). However,
epidemiological studies do not provide direct evidence or specific
clinical information about the circumstances surrounding such
events, and not all instances of these ‘early’/multiple pre-
diagnostic consultations would be associated with missed
opportunities. For example, multiple consultations may be
unavoidable in the presence of vague symptoms and/or when it
is judged reasonable to investigate patients before referral
(Lyratzopoulos et al 2014). Nonetheless, this type of evidence
strongly indicates that missed opportunities may occur in at least
some patients with cancer diagnoses and we need to understand
more about their origins, both in primary and secondary care and
throughout the diagnostic process. Further, epidemiological
evidence can help identify cancer sites or socio-demographic
characteristics of patients that confer a higher than average risk of
delayed diagnosis (Lyratzopoulos et al 2012, 2013a), providing
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Figure 1. A model for defining missed diagnostic opportunities. Adopted from Singh, 2014.
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Figure 2. Epidemiological evidence suggestive of likely missed
opportunities. Incidence rate ratios (IRR) for general practitioner
consultations before the diagnosis of cancer compared with age- and
sex-matched ‘control’ patients (without a diagnosis of cancer). Data
from Christensen et al (2012); n (women)¼63362 cancer patients and
633620 controls; n (men)¼63848 cancer patients and 638480
controls. Note very narrow 95% confidence intervals that exclude parity
(i.e., 1.00); and excess risk spanning a 12-month period, including 6
to  4 months.
Missed opportunities in cancer diagnosis BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2015.47 S85
insights into potential responsible mechanisms and targets for
further research and improvement initiatives.
TYPES AND ORIGINS OF MISSED OPPORTUNITIES IN
CANCER DIAGNOSIS
Missed opportunities for diagnosing cancer sooner may occur
anywhere in the diagnostic process. On the basis of evidence from
retrospective case reviews of cohorts of cancer patients, missed
opportunities typically occur in three main phases:
1. Initial diagnostic assessment (during the clinical encounter
between a patient and a doctor, typically, but not exclusively, a
generalist). This phase involves history taking, clinical examina-
tion and diagnostic reasoning, potentially also leading to
specialist referral, test ordering or expectant (‘safety netting’/
‘wait and see’) management decisions, or their combination.
2. Diagnostic test performance and interpretation. This phase
involves the process of performing appropriate diagnostic tests (e.g.,
blood tests, imaging or endoscopy, often at different times and
locations) and their appropriate interpretation and associated actions.
3. Diagnostic follow-up and coordination. This phase includes
many activities and tasks required to ‘close the loop’ on test
results and referrals made on initial diagnostic assessment.
Patient, provider and system factors can all contribute to the
generation of missed opportunities during one or more of the above
phases, and missed opportunities in diagnosis often involve more
than one contributory factor (Singh et al, 2013a). Complex
interactions exist between these factors; for example, both patient
and doctor factors could be influenced by system factors (Andersen
et al, 2014). Understanding the complex interplay between these
factors is important for reducing missed opportunities, thus
underscoring the importance of using multi-disciplinary approaches
in this area, including perspectives from psychology, human factors
(the scientific field that focusses on how people interact with
products, tools, procedures and processes) and informatics.
The concept of missed diagnostic opportunities builds on previous
theoretical models from psychology. For example, the ‘model of
pathways to treatment’ provides a holistic consideration of the
journey from symptom onset to diagnosis and treatment initiation,
encompassing four distinct intervals (symptom appraisal, help-
seeking, diagnostic and pre-treatment intervals), with the diagnostic
interval being of relevance to missed opportunities after presentation
as considered in this paper. (Walter et al, 2012; Scott et al, 2013).
We use the high-level taxonomy of phases described above to
illustrate different types of missed opportunities and related
contributing factors to inform and motivate further policy
initiatives and research.
Missed opportunities and contributing factors during initial
diagnostic assessment
Rigid consultation norms. In some countries (including the UK
and Denmark) medical consultation norms encourage patients to
consult for ‘one problem at a time’ (which may even have to be
declared in advance, before consultation), while the duration of
primary care appointments is typically as short as 10min (National
Health Service Information Centre, 2007; Andersen et al, 2014;
McCartney, 2014). Further, notable proportions of the public in
countries with publicly funded health-care systems worry about
consulting for symptoms that may ‘waste the doctor’s time’ (Forbes
et al, 2013). Beyond increasing the risk of delayed presentation and
help-seeking, such attitudes might also decrease patient resolve to
use up consultation time for communicating the full breadth and
complexity of their symptoms, thereby increasing the risk of
missed opportunities (Andersen et al, 2011).
Inadequate history taking and examination. For several reasons,
the full spectrum, nature and duration of symptoms may not be elicited
during a primary care encounter. Retrospective medical record reviews
of patients diagnosed with cancer indicate that insufficient symptom
elicitation or recording and ineffective doctor-patient communication
may account for many instances of missed opportunities (Singh et al,
2009a; Jensen et al, 2014). Time pressures, either real or perceived, may
impede doctors to obtain a thorough history or elicit clinical signs
when present (Andersen et al, 2014; McCartney, 2014). Other factors
described below might also contribute.
Language barriers. An increasing number of cancer patients in
Europe and North America have limited proficiency in the first
language of their resident country. In such circumstances, lack of
interpretative support may impede effective patient–doctor com-
munication, with some epidemiological evidence suggesting that
suspecting the diagnosis of cancer is less prompt (i.e., requiring a
greater number of pre-referral consultations) in older ethnic
minority patients with symptoms (Lyratzopoulos et al, 2012).
Cognitive factors impeding optimal initial clinical assessment
and reasoning. Firmly suspecting the diagnosis of cancer during a
single clinical encounter is difficult, as symptoms and signs are
rarely pathognomonic and may also be seen early in their
development (Jones et al, 2007; Hamilton 2009; Jones et al
2009). Furthermore, as public awareness campaigns, by their very
nature, encourage larger proportions of persons with symptoms to
consult, the already low positive predictive value of symptomatic
presentations in primary care for cancer may decrease further. A
range of factors may, however, make diagnostic reasoning even
more challenging. These include the following:
 Cognitive biases: several types of such biases exist, including
anchoring bias (focusing exclusively on a single item of
information), availability bias (over-reliance on already known
or easily available information) and ‘commitment to a steer’ (i.e.,
initial diagnostic impressions), which can impede diagnostic
reasoning (Kostopoulou et al, 2012; Croskerry 2013). In a study
of diagnostic errors in UK primary care, biases at the initial
framing of the problem were related to errors at the end of the
diagnostic process (Balla et al, 2012). In addition to operating
during the clinical encounter, these biases could also lead to the
misinterpretation of diagnostic test results (Singh et al, 2012a).
 Co-morbidity: consideration of a cancer diagnosis is particularly
challenging in the presence of other known non-cancer co-
morbid conditions. Many older patients (the age group at higher
risk for cancer) are multi-morbid (Barnett et al, 2012). In these
patients, symptoms compatible with the known cause of chronic
morbidity could be easily thought to reflect the pre-existing
disease rather than a new problem (Mitchell et al, 2013).
 Unfamiliarity with cancer presentations: patients with a new
diagnosis of cancer are infrequent in general practice. For example,
in the UK a full-time general practitioner on average might
encounter only between 5 and 10 new cases in a year, amid
thousands of patients with other conditions. Beyond unfamiliarity,
‘epidemiological optimism’ bias can make prompt suspicion of the
diagnosis of cancer even harder in low-risk patient groups even
when they complain of symptoms that may be due to cancer. Such
groups include young persons and certain socio-demographic
groups within specific cancers (e.g., women who present with visible
haematuria; Lyratzopoulos et al, 2012, 2013b; Nicholson et al, 2014).
Access and system capacity constraints. These are often expressed
as long waiting times. An indirect consequence of prolonged waiting
times is that they de facto increase the disease severity threshold for
referral decisions—i.e., capacity constraints influence doctor-decision
making. This may be a particular challenge for publicly funded
systems where demand management functions are implicitly delegated
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to primary care services (Vedsted and Olesen 2011; Brown et al, 2014).
Geographical barriers, such as distance to diagnostic centres, may also
be relevant, although evidence on such associations is needed.
Referral norms. The positive predictive value of signs and
symptoms for cancer is low; only a few have values45% in patients
presenting in general practice (Shapley et al, 2010). Consequently,
most patients investigated for suspected cancer will not have the
disease; for example, in the UK among patients who are referred to
specialists for suspected cancer, about 90% will be found not to have
cancer (Meechan et al, 2012). Likely peer pressure by specialists or
hospital managers may increase reluctance by primary care doctors
to refer patients if there is intolerance of low ‘diagnostic hit rates’,
increasing the risk of missed opportunities, although evidence to
further establish the role of such dynamics would be desirable.
Missed opportunities and contributing factors during diagnostic
test performance and interpretation
Patient non-adherence with recommended tests and lack of
system resilience towards such (‘no show’) events. Patients may
not adhere to prescribed investigation plans, either by not attending
recommended investigations or by not preparing for them. For
example, patient non-adherence with suggested colonoscopy inves-
tigation can lead to post-referral diagnostic delays in colorectal cancer
(Singh et al, 2012b). In Denmark, among all missed opportunities,
16% were attributable to patients not showing up (Jensen et al, 2014).
Different factors may be implicated in ‘no show’ events. Evidence
from patients not adhering to screening colonoscopy appointments
implicates emotional barriers (such as fear of an adverse diagnosis, or
fear of procedure-related pain or complications) and logistical or
communication barriers (Denberg et al, 2005), and similar factors
may be applicable to diagnostic colonoscopies. When ‘no show’
events do occur, communication with the patient and a review of the
patient’s management should be automatically triggered to resche-
dule investigations or initiate alternative management.
Diagnostic testing process complexity. The diagnosis of cancer
typically requires a sequence (‘chain’) of tests and procedures (e.g.,
blood tests, imaging, endoscopy leading to tissue sampling and
pathology reporting). These tests are by necessity often carried out at
different locations and times, whereas generalist and specialist
doctors often work in different settings, adding levels of complexity
to the diagnostic process. This high degree of complexity multiplies
the risk of delays and/or erroneous decision making at different
steps in the process by a factor proportionate to the number of
distinct tests required. Further, the distribution of the diagnostic
process (in space and time, and between primary care and specialist
care, often including different departments and locations) increases
both time lags between different steps in the process and risks of
miscommunication (Jensen et al, 2014), untimely communication or
lack of follow-up of important test results. This has, for example, in
Denmark, led to the formation of diagnostic units that enable the
conduct of multiple required tests and specialist assessments ‘within 1
day/under one roof’, and similar services are currently being
developed in the UK. Such strategies will need to be evaluated for
their effectiveness. Earlier work by the National Patient Safety
Agency has recommended that the health service needs to ‘identify,
review and disseminate current good practice in the process of
ordering, managing and tracking tests and test results’ (NPSA, 2010).
Inadequacies in the investigation strategy (initially negative tests
in the presence of ongoing symptoms or diagnostic suspicion).
This may occur when the suspicion of cancer is correctly raised but
decisions on planned investigations are sub-optimal or inadequate
(Jensen et al, 2014). This scenario may be more likely for cancers
sharing many common symptoms (e.g., cancers of pelvic/
abdominal organs). For example, a patient with abdominal
symptoms is investigated with a colonoscopy that is negative,
and this finding is initially interpreted as bringing ‘diagnostic
closure’, but the patient has persistent symptoms and is
subsequently found to have cancer of another abdominal organ
(pancreas, liver or ovary). Another example can be provided by
false-negative chest X-ray findings in patients with suspected lung
cancer (Bjerager et al, 2006; Stapley et al, 2006). Such circum-
stances can clearly prolong diagnostic intervals by providing
(temporary) false reassurance (Singh et al, 2012a). A much more
challenging situation occurs when correct tests have been carried
out but the results are falsely interpreted as negative, without
adequate fail-safe or back-up re-assessment mechanisms being
present (Singh et al, 2012a; Middleton et al, 2014).
Missed opportunities and contributing factors during follow-up
and coordination
Patient factors. If appropriately empowered, patients’ active role in
the diagnostic process can minimise the risks of missed opportu-
nities. How this potential can be harnessed should be a priority for
future research (McDonald et al, 2013). The National Patient Safety
Agency report on diagnostic delays in cancer recommended that the
health service ‘develop methods for empowering patients on a
cancer diagnostic pathway’ (NPSA, 2010). However, currently:
 Many patients do not feel empowered to seek out the results of
tests performed on them, or do not know how to do so. Patients
may also be ‘reassured’ by lack of follow-up by doctors/the
health-care system, interpreting lack of communication to mean
that ‘all is normal’ in instances when this is not the case. This
emphasises the importance of passive (‘open door’) or active
(fixed interval, e.g., 3-week clinical review) follow-up as part of
safety-netting strategies (Almond et al, 2009).
 Patients also might not be willing to re-consult or seek a second
medical opinion despite doubting the certainty of their diagnosis
and persistent or worsening symptoms (Birt et al, 2014;
McDonald et al, 2013).
 Another common occurrence is patients not returning for ‘fail-
safe/safety-netting’ visits planned as part of expectant management
strategies, and/or when they experience persistent, worsening or
new symptoms (Singh et al, 2012a; Mitchell et al, 2013). Factors
similar to those involved in non-adherence with diagnostic
investigations may be implicated (see ‘Missed opportunities and
contributing factors during diagnostic test performance and
interpretation’, above). Robust mechanisms for identification of
such occurrences and contact with patients are required.
Over-reliance on patients to ‘call back’. Doctors often believe that
patients will call if they do not feel better or new symptoms develop,
and often assume that the diagnosis they had recently given had
been correct if they do not hear otherwise (Singh and Sittig, 2014).
Ensuring timely patient follow-up could also help prevent missed
opportunities that relate to coordination failures between different
clinics, hospital departments and general practices (Mitchell et al,
2013). Proactive follow-up systems and protocols that leverage
information technology might be needed to minimise the risk of
such missed opportunities ‘at the last hurdle’ (Murphy et al, 2014).
Lack of appreciation or follow-up of abnormal test results.
Increasingly recognised in ‘electronic health record-enabled’
health-care systems are instances of failure to recognise and act
on abnormal tests related to cancer (Murphy et al, 2014). Many
reasons could contribute to such occurrences—for example,
physician ‘alert fatigue’ or ambiguities about the health-care
professional who is ‘in charge’ of the patient and responsible for
follow-up (Singh et al, 2009b). Informational continuity and
clarity of accountability for the patient as they progress through
the diagnostic pathway poses remarkable challenges (Press, 2014).
Because modern health care is delivered by teams rather than by
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individuals, factors relating to team dynamics and ‘distributed
cognition’ could also be relevant; these include low staff morale,
poor communication between team members and limited
‘situational awareness’ of diagnostic safety (Singh et al, 2012a).
MEASUREMENT, LEARNING AND IMPROVEMENT
As is the case for safety interventions in general, identification
of instances where missed opportunities have occurred is a
pre-requisite for motivating and guiding organisational learning
and improvement efforts and service redesign (Donaldson et al,
2014). Although we acknowledge that not all missed opportunities
or delays would directly result in poorer patient outcomes
(see also Figure 1), we believe that all preventable diagnostic
delays should be avoided. Additional reasons to do so include
strong patient (and carer) preferences for prompt diagnosis of cancer
and substantial burden of patient complaints and medico-legal claims
associated with diagnostic delays/missed diagnostic opportunities
(Gandhi et al, 2006; Schiff et al, 2013).
Measurement of missed opportunities relies on operational
definitions that may vary between settings and systems. Ideally,
measures with optimal construct validity should be developed
(Singh and Sittig, 2015). However, this is difficult to achieve given
the current state of the evidence and scientific knowledge related to
diagnostic safety. We therefore suggest that resources should be
prioritised for developing and using ‘surrogate markers’ of missed
opportunities, which could ‘trigger’ clinical audit activity and case
reviews to verify the presence and nature of missed opportunities
and likely contributory factors. Different possible surrogate
markers (or triggers) have been proposed in the literature,
including unusual patterns of multiple consultations (‘return
visits’), emergency presentations (Elliss-Brookes et al, 2012;
Lyratzopoulos et al, 2012; Mitchell et al, 2013; Singh et al, 2013a;
Jensen et al, 2014) or symptoms or abnormal test findings
suggesting the need for diagnostic evaluation for cancer (Murphy
et al, 2014). Another approach is doctor-led retrospective reviews
of all or randomly selected cases of cancer diagnosed in a practice
or health centre during defined periods (Baughan et al, 2009;
Rubin et al, 2011; Mitchell et al, 2013). Patient record audits offer
several advantages, including detailed information and longitudinal
data about symptoms, investigations and diagnosis evolution, but
their limitations include the potential for hindsight bias, missing
documentation and review time (Zwaan et al, 2010). Although no
criterion or method to define missed opportunities is 100%
sensitive and specific, the use of markers/triggers can motivate and
support quality improvement activities and professional and
organisational learning.
We summarise common factors involved in missed opportu-
nities and list a range of possible actions in Table 1, acknowledging
that evidence on the effectiveness of cognitive and system
interventions is still emerging and there is a need for further
research and evaluation in relevant areas (Graber et al, 2012; Singh
et al, 2012c).
IMPLICATIONS FOR RESEARCH AND POLICY. ENRICHING
THE SPECTRUM OF POST-PRESENTATION
INTERVENTIONS TO PROMOTE EARLY DIAGNOSIS
Recently, an Institute of Medicine (IOM) committee was tasked
with evaluating diagnostic error as a patient safety issue (IOM,
2014). As this new report will be a continuation of the IOM’s
Health Care Quality Initiative report ‘To Err is Human: Building a
Safer Health System and Crossing the Quality Chasm: A New
Health System for the 21st Century’, the importance of early diagnosis
and of improving diagnostic safety for both researchers and policy-
makers is likely to increase substantially in the coming years.
Several policies aimed at expediting the diagnosis of cancer
after presentation to general practitioners chiefly emphasise
either ‘knowledge mobilisation’ interventions (e.g., reminding
primary care physicians of the possibility of cancer diagnosis
during consultations), or enabling of greater access to endoscopy
or imaging investigations (Department of Health, 2012;
Hamilton et al, 2013). Although critically important, such
interventions address only some of the multitude of factors
along all phases of the diagnostic process that can contribute to
missed opportunities in cancer diagnosis. In addition, they tend
to focus on primary care rather than keeping a system-wide focus
and addressing factors during the medical encounter as well as
the performance of tests and follow-up and coordination beyond
the initial clinical encounter. Further, in both primary and
secondary care we are yet to understand why physicians (both
generalists and specialists) at times do not recognise or act upon
obvious alarm symptoms or signs of cancer. Factors such as
doctors’ tiredness or stress, information overload (‘alert fatigue’),
poor communication between primary and secondary care, and
team dynamics are likely to be involved in such events (Singh
et al, 2012a, 2013b). In contemporary complex and information
technology-enabled health-care environments, acquiring
such an understanding requires disciplinary inputs from the
fields of psychology and behavioural/social sciences, human
factors, systems engineering and clinical informatics. A systems
approach to the problem of diagnostic safety is needed, as it is
currently applied to surgical safety (Vincent et al, 2004).
Interventions focussing only one factor—for example, solely
aiming to optimise clinical reasoning during primary care
encounters—might not be comprehensive enough, given that
most instances of missed diagnostic opportunities typically
involve several contributing factors.
We thus recommend that multi-disciplinary and multi-faceted
approaches be developed to target the various phases in the
diagnostic process where missed opportunities occur. These
interventions should address the full range of contributing factors
beyond mere individual cognitive or system capacity constraints.
Because cancer diagnosis is distributed across time and place and
involves interactions among multiple human and system compo-
nents, these approaches should aim to strengthen both human and
system performance and account for concepts such as shared
mental models, distributed cognition and optimal technology use
(Karsh et al, 2006; Henriksen and Brady, 2013; Smith et al, 2014).
Newer forms of diagnostic and information technologies are being
suggested to improve the diagnosis of cancer (e.g., electronic health
records to enable informational continuity between different
providers) requiring input from the field of clinical informatics
(El-Kareh et al, 2013). However, although technological innovation
can be helpful, many factors unrelated to technology can
contribute to missed opportunities across all phases of the
diagnostic process and must also be addressed. This can be
achieved by a deeper understanding of ‘socio-technical’ factors
implicated in missed opportunities (workflow and organisational
factors among others; Sittig and Singh, 2010). Multi-faceted
approaches will enrich the spectrum of intervention targets,
beyond facilitation of symptom recognition or access to specialist
diagnostic assessment.
In conclusion, we call for more multi-disciplinary research that
targets factors contributing to missed opportunities in all phases of
the diagnostic process. The fields of organisational and cognitive
psychology, human factors science and clinical informatics can all
provide valuable insights into this emerging research agenda.
Building on current approaches, we have provided a theoretical
basis for the development of future interventions to shorten
diagnostic intervals post presentation. The conceptual foundation
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we provide could motivate multi-disciplinary and multi-faceted
strategies aimed at minimising the occurrence of missed diagnostic
opportunities in cancer, enriching current approaches that
principally focus on clinical decision support or on widening
access to investigations.
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Table 1. Future initiatives and research agenda to address missed opportunities
Possible practical steps/policies Future research agenda Potential fields involveda
Re-engineering of medical consultation norms and improving the quality of history taking and examination
Allocation of additional consultation time, particularly for
infrequent attenders or multi-morbid patients (Andersen et al,
2014; McCartney, 2014)
Patient engagement initiatives bolstering confidence in
communicating symptoms and in not feeling that they ‘are
wasting the doctors’ time’ (Andersen et al, 2011; Forbes et al,
2013)
Ensuring formal or informal (e.g., family/relative) translation
services for patients who are not competent in routine
consultation language (e.g., ethnic minority patients)
Further quantification and qualification of
mechanisms leading to ineffective symptom
communication or elicitation during the
patient encounter, and its implications
Social science
Behavioural science
Medical anthropology
Policy
Primary care
Health services research
Reducing cognitive or system barriers to optimal initial clinical assessment and reasoning
Effective decision support tools/diagnostic checklists to help
minimise the risk of not thinking about a diagnosis of cancer in
patients with common presentations and those with lower risk/
atypical symptoms (Ely et al, 2011; Hamilton et al, 2013)
Optimising decision making about investigation plans by
increasing capacity/enabling prompt primary care access to
specialist investigations and their prompt reporting
Cultural shift towards accepting ‘low diagnostic hit rates’. Re-
modelling of diagnostic quality norms from kudos given to
doctors for ‘being right’ to kudos given to doctors for ‘being
safe’
Further evaluation of the use and impact of
clinical decision support tools and diagnostic
checklists in randomised controlled trials
Evaluate the impact of additional consultation
time, diagnostic services reorganisation, and
increasing capacity on measures of diagnostic
quality and safety
Clinical informatics
Cognitive psychology
Human factors
Policy
Primary care
Health services research
Improving diagnostic test performance, interpretation and follow-up
Development of resilient/fail-safe systems for following up and/
or rebooking patient ‘no show’ instances (for test performance
or ‘expectant management’ follow-up), or patients with
negative test results but persistent/evolving symptoms
Reorganisation of diagnostic pathways to allow for multi-
processing of tests in ‘one-stop’ clinics (all tests ‘under one roof,
during one day’) and wider access to specialist investigations
Empowering of patients regarding outcomes of diagnostic
investigations. Solutions may include sharing of patient records
and enabling active chasing of test results by patients (Feeley and
Shine, 2011)
Effective electronic health record-enabled systems to ensure that
diagnostic tests with abnormal results are acted upon by the
relevant clinician
Use of ‘navigators’ (volunteers or professional staff) for complex
cases (e.g., multiple tests, high/worsening symptom burden,
patients with poor social support and/or other communication or
transport difficulties; (Press, 2014)
Robustly evaluate the effectiveness of new
models of diagnostic care (Guldbrandt et al,
2014)
Explore optimal back-up tracking support
systems for optimising diagnostic safety in
electronic health record-enabled systems
Organisational
psychology
Human factors
Clinical informatics
Systems engineering
Behavioural science
Social science
Policy
Health services research
Nursing
aThis is an indicative list of relevant disciplines that should not be considered as ‘future proof’: input from scientific fields beyond those mentioned may also be needed, as knowledge in this
area is evolving.
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